G1 Therapeutics: Q1 Earnings Insights

G1 Therapeutics GTHX reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.

Earnings

G1 Therapeutics missed estimated earnings by 18.56%, reporting an EPS of $-1.15 versus an estimate of $-0.97.

Revenue was down $7.32 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.09 which was followed by a 12.3% increase in the share price the next day.

Here's a look at G1 Therapeutics's past performance:

To track all earnings releases for G1 Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.